Natera
Official SEC filings
Source: SEC EDGAR. Latest available cached filings; filing date is not the financial period end. Index checked: 2026-11-19 15:43 UTC.
| Form | Filed | Original document |
|---|---|---|
| 10-Q | 2026-11-05 | Read on SEC.gov |
| 8-K | 2026-11-05 | Read on SEC.gov |
| 10-Q | 2026-08-07 | Read on SEC.gov |
| 8-K | 2026-08-06 | Read on SEC.gov |
| 8-K | 2026-07-06 | Read on SEC.gov |
| 8-K | 2026-06-16 | Read on SEC.gov |
| 8-K | 2026-06-05 | Read on SEC.gov |
| 10-Q | 2026-05-08 | Read on SEC.gov |
SEC annual financial snapshot
Standard US-GAAP facts in 10-K filings, USD. Income and cash flow cover the annual period; balance-sheet amounts are as of period end. These are not quarterly or TTM figures. Latest available filed values may include restatements; reporting periods can differ from other providers. Checked: 2026-11-22 03:51 UTC.
| Metric | USD | Basis | Period end | Filed | Source |
|---|---|---|---|---|---|
| Revenue | $2.31B | Annual | 2025-12-31 | 2026-02-27 | 10-K |
| Net income | $-208.16M | Annual | 2025-12-31 | 2026-02-27 | 10-K |
| Operating cash flow | $215.30M | Annual | 2025-12-31 | 2026-02-27 | 10-K |
| Total assets | $2.40B | As of | 2025-12-31 | 2026-02-27 | 10-K |
| Total liabilities | $685.93M | As of | 2025-12-31 | 2026-02-27 | 10-K |
| Stockholders’ equity | $1.71B | As of | 2025-12-31 | 2026-02-27 | 10-K |
✦ Quant Financial Health how this is computed
- Altman Z-Score is 34.12, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +35.90% YoY
Margins
- Gross margin
- 64.75%
- Operating margin
- -13.44%
- Net margin
- -9.03%
Key ratios & quality
- Altman Z-Scorei
- 34.12
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 257.65M | 302.33M | 391.01M | 625.49M | 820.22M | 1.08B | 1.70B | 2.31B |
| Gross profit | 91.60M | 126.86M | 187.39M | 307.07M | 363.97M | 492.74M | 1.02B | 1.49B |
| Selling & admin expenses | 154.87M | 206.18M | 303.63M | 511.03M | 588.59M | 618.31M | 841.31M | 1.18B |
| Research & development | 51.36M | 51.36M | 100.04M | 264.21M | 316.42M | 320.68M | 404.14M | 624.11M |
| Operating profit | -114.63M | -130.68M | -216.28M | -468.17M | -541.04M | -446.25M | -222.29M | -309.91M |
| Pretax profit | -127.83M | -122.83M | -229.65M | -471.10M | -546.82M | -434.53M | -189.73M | -268.09M |
| Tax | 321.00K | 2.00M | 98.00K | 618.00K | 978.00K | 271.00K | 695.00K | -59.93M |
| Net profit | -128.15M | -124.83M | -229.74M | -471.72M | -547.80M | -434.80M | -190.43M | -208.16M |
| Basic EPS | -2 | -2 | -3 | -5 | -6 | -4 | -2 | -2 |
| Diluted EPS | -2.22 | -1.79 | -2.84 | -5.21 | -5.57 | -3.78 | -1.53 | -1.52 |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Revenue | 546.60M | 592.18M | 665.50M | 696.64M | 752.75M | 793.98M |
| Gross profit | 346.60M | 384.38M | 445.43M | 450.83M | 485.19M | 513.47M |
| Selling & admin expenses | 310.55M | 308.55M | 291.30M | 327.94M | 327.20M | 333.66M |
| Research & development | 146.43M | 173.41M | 175.19M | 210.70M | 228.07M | 242.43M |
| Operating profit | -110.37M | -97.58M | -22.79M | -93.52M | -75.79M | -68.32M |
| Pretax profit | -100.66M | -87.34M | -13.33M | -84.81M | -67.23M | -59.61M |
| Tax | 275.00K | 207.00K | -60.58M | 283.00K | -261.00K | 299.00K |
| Net profit | -100.94M | -87.54M | 47.26M | -85.09M | -66.97M | -59.91M |
| Basic EPS | -1 | -1 | 0 | -1 | 0 | 0 |
| Diluted EPS | -0.74 | -0.64 | 0.36 | -0.60 | -0.47 | -0.42 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 240.52M | 523.17M | 862.66M | 1.09B | 1.21B | 1.26B | 1.38B | 1.50B |
| Cash & ST investments | 153.87M | 440.99M | 737.27M | 914.28M | 898.39M | 878.98M | 968.28M | 1.08B |
| Inventory | 13.63M | 12.39M | 20.03M | 26.91M | 35.41M | 40.76M | 44.74M | 68.44M |
| Total assets | 268.17M | 582.66M | 932.15M | 1.24B | 1.39B | 1.44B | 1.66B | 2.40B |
| Total current liabilities | 113.98M | 179.87M | 199.05M | 218.96M | 310.50M | 307.27M | 344.05M | 441.23M |
| Short-term debt | 50.15M | 55.86M | 57.35M | 55.80M | 87.99M | 92.02M | 90.53M | 95.90M |
| Long-term debt | 73.36M | 73.66M | 202.49M | 280.39M | 281.65M | 282.95M | -- | -- |
| Total liabilities | 236,009,000.00 | 303,945,000.00 | 445,917,000.00 | 583,183,000.00 | 688,730,000.00 | 676,372,000.00 | 465,315,000.00 | 685,931,000.00 |
| Total equity | 32.16M | 278.71M | 486.24M | 653.30M | 705.74M | 765.33M | 1.20B | 1.71B |
| Retained earnings | -574.53M | -699.17M | -929.32M | -1.39B | -1.94B | -2.38B | -2.57B | -2.78B |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Total current assets | 1.43B | 1.45B | 1.50B | 1.65B | 1.66B | 1.72B |
| Cash & ST investments | 1.02B | 1.04B | 1.08B | 1.09B | 1.09B | 1.10B |
| Inventory | 54.27M | 64.64M | 68.44M | 70.72M | 80.35M | 91.70M |
| Total assets | 1.76B | 1.82B | 2.40B | 2.61B | 2.66B | 2.75B |
| Total current liabilities | 384.84M | 442.02M | 441.23M | 558.26M | 553.20M | 612.90M |
| Short-term debt | 93.39M | 94.35M | 95.90M | 95.13M | 95.41M | 96.23M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 510,884,000.00 | 569,294,000.00 | 685,931,000.00 | 840,380,000.00 | 835,998,000.00 | 878,857,000.00 |
| Total equity | 1.25B | 1.25B | 1.71B | 1.77B | 1.82B | 1.87B |
| Retained earnings | -2.74B | -2.82B | -2.78B | -2.86B | -2.93B | -2.99B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -70.58M | -63.44M | -182.51M | -335.24M | -431.50M | -246.96M | 135.66M | 215.30M |
| Depreciation & amortization | 7.50M | 7.73M | 8.61M | 11.25M | 16.70M | 24.10M | 30.97M | 43.48M |
| Free cash flow | -74.46M | -68.41M | -202.12M | -376.27M | -479.20M | -286.15M | 58.75M | 76.11M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 96.78M | 323.41M | 270.65M | 550.82M | 433.19M | 235.44M | 0 | 0 |
| Ending cash balance | 51.00M | 61.98M | 48.86M | 84.61M | 466.09M | 642.10M | 945.59M | 1.08B |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Operating cash flow | 37.57M | 59.39M | 73.89M | 40.17M | 54.79M | 43.93M |
| Depreciation & amortization | 9.86M | 10.29M | 14.10M | 20.23M | 21.19M | 21.97M |
| Free cash flow | 11.68M | 24.48M | 17.32M | 18.03M | -8.64M | 5.25M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 1.00B | 1.04B | 1.08B | 1.09B | 1.09B | 1.10B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -1,176.16 | -80.31 | -60.07 | -82.79 | -80.62 | -59.11 | -19.42 | -14.32 |
| ROA %i | -57.35 | -29.34 | -30.33 | -43.50 | -41.64 | -30.66 | -12.28 | -10.26 |
| ROIC %i | -89.77 | -40.68 | -37.32 | -51.66 | -49.35 | -37.60 | -16.58 | -14.54 |
| 5-year avg ROE %i | -- | -369.92 | -172.62 | -175.40 | -149.78 | -72.58 | -60.40 | -51.25 |
| EBIT margin %i | -45.55 | -37.09 | -54.87 | -73.99 | -65.53 | -38.97 | -10.55 | -11.45 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- | 3.46 | 3.30 |
| Current ratioi | 2.11 | 2.91 | 4.33 | 4.99 | 3.90 | 4.10 | 4.00 | 3.39 |
| Quick ratioi | 1.90 | 2.75 | 4.10 | 4.73 | 3.68 | 3.77 | 3.73 | 3.11 |
| Debt / assetsi | 46.06 | 26.74 | 30.16 | 32.13 | 32.00 | 30.66 | 11.27 | 8.94 |
| LT debt / equityi | 228.09 | 35.86 | 46.01 | 52.26 | 50.76 | 45.73 | 8.08 | 6.92 |
| Interest coveragei | -11.20 | -10.49 | -14.23 | -55.72 | -57.68 | -33.38 | -16.76 | -64.89 |
| Revenue CAGR (3Y) %i | 10.62 | 12.47 | 23.10 | 34.40 | 39.47 | 40.42 | 39.47 | 41.14 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| ROE %i | -24.32 | -29.02 | -14.32 | -15.02 | -12.54 | -10.55 |
| ROA %i | -15.47 | -18.12 | -10.26 | -10.41 | -8.71 | -7.21 |
| ROIC %i | -21.60 | -25.03 | -14.54 | -14.87 | -12.59 | -10.71 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -12.57 | -14.43 | -11.45 | -11.28 | -9.19 | -7.61 |
| FCF / sales %i | 5.32 | 4.42 | 3.30 | 2.86 | 1.89 | 1.10 |
| Current ratioi | 3.72 | 3.27 | 3.39 | 2.96 | 3.00 | 2.81 |
| Quick ratioi | 3.44 | 3.01 | 3.11 | 2.70 | 2.74 | 2.56 |
| Debt / assetsi | 11.16 | 10.91 | 8.94 | 9.18 | 8.97 | 8.69 |
| LT debt / equityi | 8.24 | 8.34 | 6.92 | 8.17 | 7.85 | 7.63 |
| Interest coveragei | -38.18 | -69.91 | -64.89 | -71.33 | -65.20 | -60.20 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Quote time 2026-11-20 20:02:26 · For reference only, not investment advice and not tailored to your situation.
Natera discussion 0 comments